Cytoplasmic retention of mutant tsp53 is dependent on an intermediate filament protein (Vimentin) scaffold

被引:49
作者
Klotzsche, O [1 ]
Etzrodt, D [1 ]
Hohenberg, H [1 ]
Bohn, W [1 ]
Deppert, W [1 ]
机构
[1] Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, D-20251 Hamburg, Germany
关键词
nuclear exclusion; cytoplasmic anchorage; temperature sensitive mutant p53; vimentin; intermediate filaments; C6 rat glioma cells;
D O I
10.1038/sj.onc.1202155
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The temperature-sensitive mutant tsp(val135) accumulates in the cytoplasm of cells kept at the non-permissive temperature (39 degrees C), but is rapidly transported into the cell nucleus at the permissive temperature (30 degrees C). tsp53 thus may serve as a model for analysing cellular parameters influencing the subcellular location of p53. Here we provide evidence that retention of tsp53 in the cytoplasm at the non-permissive temperature is due to cytoskeletal anchorage of the p53 protein. Two sublines of C6 rat glioma cells differing in their expression of the intermediate filament protein vimentin (vimentin expressing or vimentin negative cells) were stably transfected with a vector encoding tsp53, Whereas cells of vimentin expressing C6 subclones retained tsp53 in the cytoplasm at the non-permissive temperature, cells of vimentin negative subclones exclusively harbored the tsp53 within their nuclei. Intermediate filament deficient cells that had been reconstituted with a full length vimentin protein again shelved a cytoplasmic localization of tsp53, whereas in cells expressing a C-terminally truncated (tail-less) vimentin tsp53 localized to the nucleus, We conclude that cytoplasmic sequestration of tsp53 requires an intact intermediate filament system.
引用
收藏
页码:3423 / 3434
页数:12
相关论文
共 62 条
[11]  
DEPPERT W, 1994, SEMIN CANCER BIOL, V5, P187
[12]  
DEPPERT W, 1994, INT CONGR SER, V1050, P11
[13]   GAIN OF FUNCTION MUTATIONS IN P53 [J].
DITTMER, D ;
PATI, S ;
ZAMBETTI, G ;
CHU, S ;
TERESKY, AK ;
MOORE, M ;
FINLAY, C ;
LEVINE, AJ .
NATURE GENETICS, 1993, 4 (01) :42-46
[14]  
ECKELT A, 1992, EUR J CELL BIOL, V58, P319
[15]  
Eizenberg O, 1996, MOL CELL BIOL, V16, P5178
[16]   OVERPRODUCTION OF P53 ANTIGEN MAKES ESTABLISHED CELLS HIGHLY TUMORIGENIC [J].
ELIYAHU, D ;
MICHALOVITZ, D ;
OREN, M .
NATURE, 1985, 316 (6024) :158-160
[17]   Distribution and ultrastructure of plectin arrays in subclones of rat glioma C-6 cells differing in intermediate filament protein (vimentin) expression [J].
Foisner, R ;
Bohn, W ;
Mannweiler, K ;
Wiche, G .
JOURNAL OF STRUCTURAL BIOLOGY, 1995, 115 (03) :304-317
[18]  
GANNON JV, 1991, NATURE, V349, P802
[19]   p53 in growth control and neoplasia [J].
Gottlieb, TM ;
Oren, M .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1996, 1287 (2-3) :77-102
[20]   Database of p53 gene somatic mutations in human tumors and cell lines: Updated compilation and future prospects [J].
Hainaut, P ;
Soussi, T ;
Shomer, B ;
Hollstein, M ;
Greenblatt, M ;
Hovig, E ;
Harris, CC ;
Montesano, R .
NUCLEIC ACIDS RESEARCH, 1997, 25 (01) :151-157